Health Care·Health Care Technology·$1.1B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $-0.34 | N/A | +4.93% |
| Revenue | N/A | N/A | N/A |
management commentary, guidance changes, and full analysis available with Pro.
| EPS | $-0.34 | N/A | +4.93% |
| Revenue | N/A | N/A | N/A |
Tone: Cautiously Optimistic
Management expressed a cautious optimism about future growth, focusing on technological advancements. They reiterated their commitment to improving user experience.
Management highlighted ongoing investments in technology and customer engagement.
They emphasized the importance of expanding their service offerings to attract more users.
Teladoc's earnings report showed a narrower-than-expected loss per share, which led to a slight increase in stock price. However, the lack of revenue data and guidance may leave investors cautious. The stock's modest rise suggests that investors are somewhat reassured by the EPS surprise, even without detailed revenue insights.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
AVALONBAY CMNTYS INC REIT
Oct 29, 2018